Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy

World Journal of Gastroenterology

Volumn 19, Issue 11, 2013, Pages 1673-1682

  Iwamoto, Junichi ^a   Saito, Yoshifumi ^a   Honda, Akira ^a   Matsuzaki, Yasushi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastroduodenal ulcer; Low dose aspirin; Non steroidal anti infammatory drugs; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 1; DIPYRIDAMOLE; ESOMEPRAZOLE; FAMOTIDINE; GEFARNATE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; REBAMIPIDE; TICLOPIDINE;

ANGIOGENESIS; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HEALING IMPAIRMENT; HELICOBACTER INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; LEUKOCYTE ADHERENCE; META ANALYSIS (TOPIC); PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCOSA INJURY; THROMBOCYTE AGGREGATION;

EID: 84875386334     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i11.1673     Document Type: Editorial

References (68)

1. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet 1991; 338: 1345-1349 [PMID: 1682734 DOI: 10.1016/0140-6736(91)92233-R]
2. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308: 81-106 [DOI: 10.1136/bmj.308.6921.81]
3. Lauer MS. Clinical practice. Aspirin for primary prevention of coronary events. N Engl J Med 2002; 346: 1468-1474 [PMID: 12000818]
4. Lorenz RL, Schacky CV, Weber M, Meister W, Kotzur J, Reichardt B, Theisen K, Weber PC. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1984; 1: 1261-1264 [PMID: 6144975]
5. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349-360 [PMID: 2899772]
6. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86 [PMID: 11786451 DOI: 10.1136/bmj.324.7336.S71]
7. Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal pros-taglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17-25 [PMID: 10381905 DOI: 10.1016/S0016-5085(99)70545-7]
8. Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007; 23: 163-173 [PMID: 17257477 DOI: 10.1185/030079907X162656]
9. Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16: 1945-1953 [PMID: 12390104 DOI: 10.1046/j.1365-2036.2002.01355.x]
10. Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Stef-fensen FH, McLaughlin JK, Olsen JH. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 2218-2224 [PMID: 11007221 DOI: 10.1016/S0002-9270(00)01040-6]
11. Nakashima S, Arai S, Mizuno Y, Yoshino K, Ando S, Naka-mura Y, Sugawara K, Koike M, Saito E, Naito M, Nakao M, Ito H, Hamaoka K, Rai F, Asakura Y, Akamatu M, Fujimori K, Inao M, Imai Y, Ota S, Fujiwara K, Shiibashi M. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-infammatory drugs. Aliment Pharmacol Ther 2005; 21 Suppl 2: 60-66 [PMID: 15943849 DOI: 10.1111/j.1365-2036.2005.02476.x]
12. Yeomans ND, Lanas AI, Talley NJ, Thomson AB, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Långström G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005; 22: 795-801 [PMID: 16225488 DOI: 10.1111/ j.1365-2036.2005.02649.x]
13. Ishikawa S, Inaba T, Mizuno M, Okada H, Kuwaki K, Ku-zume T, Yokota H, Fukuda Y, Takeda K, Nagano H, Wato M, Kawai K. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-infammatory drugs in Japan. Acta Med Okayama 2008; 62: 29-36 [PMID: 18323869]
14. Niv Y, Battler A, Abuksis G, Gal E, Sapoznikov B, Vilkin A. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci 2005; 50: 78-80 [PMID: 15712641 DOI: 10.1007/ s10620-005-1281-1]
15. Nema H, Kato M, Katsurada T, Nozaki Y, Yotsukura A, Yoshida I, Sato K, Kawai Y, Takagi Y, Okusa T, Takiguchi S, Sakurai M, Asaka M. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease. J Gastroenterol Hepatol 2008; 23 Suppl 2: S234-S236 [PMID: 19120904 DOI: 10.1111/ j.1440-1746.2008.05411.x]
16. Nema H, Kato M, Katsurada T, Nozaki Y, Yotsukura A, Yoshida I, Sato K, Kawai Y, Takagi Y, Okusa T, Takiguchi S, Sakurai M, Asaka M. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease. J Clin Gastroenterol 2009; 43: 130-132 [PMID: 18779739 DOI: 10.1097/MCG.0b013e3181580e8a]
17. Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet 2009; 374: 119-125 [PMID: 19577798 DOI: 10.1016/S0140-6736(09)61246-0]
18. Scheiman JM, Devereaux PJ, Herlitz J, Katelaris PH, Lanas A, Veldhuyzen van Zanten S, Nauclér E, Svedberg LE. Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart 2011; 97: 797-802 [PMID: 21415072 DOI: 10.1136/hrt.2010.217547]
19. Sugano K, Matsumoto Y, Itabashi T, Abe S, Sakaki N, Ashida K, Mizokami Y, Chiba T, Matsui S, Kanto T, Shimada K, Uchiyama S, Uemura N, Hiramatsu N. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol 2011; 46: 724-735 [PMID: 21499703 DOI: 10.1007/s00535-011-0397-7]
20. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev 2008; 88: 1547-1565 [PMID: 18923189 DOI: 10.1152/phys-rev.00004.2008]
21. Konturek SJ, Obtulowicz W, Sito E, Oleksy J, Wilkon S, Kiec-Dembinska A. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol. Gut 1981; 22: 283-289 [PMID: 7239320 DOI: 10.1136/gut.22.4.283]
22. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000; 119: 706-714 [PMID: 10982765 DOI: 10.1053/gast.2000.16510]
23. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanay-em BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced infammation and indomethacin-induced gastric ulceration. Cell 1995; 83: 483-492 [PMID: 8521478 DOI: 10.1016/0092-867 4(95)90126-4]
24. Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-infammatory drug-induced gastric damage. Am J Med 1989; 86: 449-458 [PMID: 2648824 DOI: 10.1016/0002-9343(89)9034 4-6]
25. Hiraishi H, Shimada T, Terano A. Involvement of oxidative stress in the pathogenesis of NSAID-induced gastric mucosal damage. J Gastroenterol 2000; 35: 567-569 [PMID: 10905368 DOI: 10.1007/s005350070083]
26. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-infammatory drugs. Aliment Pharmacol Ther 2005; 22: 285-289 [PMID: 16097994 DOI: 10.1111/j.1365-2036.2005.02560.x]
27. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830 [PMID: 7711618 DOI: 10.1136/bmj.310.6983.827]
28. Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yo-shida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, Kuwayama H, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Perez-Gutthann S, Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-infammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62: 765-772 [PMID: 16821007 DOI: 10.1007/s00228-006-0171-6]
29. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-1187 [PMID: 11073508 DOI:10.1136/bmj0321.7270.1183]
30. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002; 162: 2197-2202 [PMID: 12390062 DOI: 10.1001/archinte.162.19.2197]
31. Steinhubl SR, Topol EJ. Risk reduction with long-term clopidogrel following percutaneous coronary intervention. Eur Heart J 2004; 25: 2169-2270; author reply 2169-270; [PMID: 15571836 DOI: 10.1016/j.ehj.2004.09.016]
32. Ibáñez L, Vidal X, Vendrell L, Moretti U, Laporte JR. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006; 23: 235-242 [PMID: 16393302 DOI: 10.1111/j.1365-2036.2006.02759.x]
33. Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006; 333: 726 [PMID: 16984924 DOI: 10.1136/ bmj.38947.697558.AE]
34. García Rodríguez LA, Hernández-Díaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 2004; 159: 23-31 [PMID: 14693656 DOI: 10.1093/aje/kwh005]
35. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 1413-1416 [PMID: 8937281 DOI: 10.1016/ S0140-6736(96)01254-8]
36. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888-1899 [PMID: 10369853 DOI: 10.1056/ NEJM199906173402407]
37. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22 [PMID: 11809181 DOI: 10.1016/S0140-6736(02)07273-2]
38. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sáinz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 779-786 [PMID:11929396 DOI:10.1046/j.1365-2036.2002.01230.x]
39. Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson AB, Yeomans ND. Predictors of gastroduodenal erosions in patients taking low-dose aspirin. Aliment Pharmacol Ther 2010; 31: 143-149 [PMID: 19709095 DOI: 10.1111/ j.1365-2036.2009.04133.x]
40. Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S, Güell M, de Argila CM, Quintero E, Borda F, Piqué JM. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-infammatory drugs, aspirin and combinations. Gut 2006; 55: 1731-1738 [PMID: 16687434 DOI: 10.1136/gut.2005.080754]
41. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-1255 [PMID: 10979111 DOI: 10.1001/ jama.284.10.1247]
42. García Rodríguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroen-terology 2007; 132: 498-506 [PMID: 17258728 DOI: 10.1053/j.gastro.2006.12.007]
43. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 2002; 123: 1451-1458 [PMID: 12404219 DOI: 10.1053/gast.2002.36556]
44. Kawai T, Yamagishi T, Goto S. Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. J Atheroscler Thromb 2009; 16: 155-163 [PMID: 19556719]
45. Iwamoto J, Mizokami Y, Shimokobe K, Ito M, Hirayama T, Saito Y, Ikegami T, Honda A, Matsuzaki Y. Clinical features of gastroduodenal ulcer in Japanese patients taking low-dose aspirin. Dig Dis Sci 2010; 55: 2270-2274 [PMID: 19936921]
46. Shiotani A, Sakakibara T, Yamanaka Y, Imamura H, Tarumi K, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol 2009; 44: 126-131 [PMID: 19214674 DOI: 10.1007/s00535-008-2290-6]
47. Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rens-burg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol 2008; 103: 2465-2473 [PMID: 18637091 DOI: 10.1111/j.1572-0241.2008.01995.x]
48. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Aliment Pharmacol Ther 2006; 23: 489-495 [PMID: 16441469 DOI: 10.1111/j.1365-2036.2006.02784.x]
49. Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Go-mollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastro-enterol 2007; 102: 507-515 [PMID: 17338735 DOI: 10.1111/ j.1572-0241.2006.01062.x]
50. Ng FH, Wong SY, Lam KF, Chu WM, Chan P, Ling YH, Kng C, Yuen WC, Lau YK, Kwan A, Wong BC. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 2010; 138: 82-88 [PMID: 19837071 DOI: 10.1053/j.gatro.2009.09.063]
51. Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-244 [PMID: 15659723 DOI: 10.1056/NEJMoa042087]
52. Tildesley G, Ehsanullah RS, Wood JR. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs. Br J Rheumatol 1993; 32: 474-478 [PMID: 8508283 DOI: 10.1093/rheumatol-ogy/32.6.474]
53. Mizokami Y. Efficacy and safety of rabeprazole in non-steroidal anti-inflammatory drug-induced ulcer in Japan. World J Gastroenterol 2009; 15: 5097-5102 [PMID: 19860005]
54. Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-infam-matory therapy and receiving treatment with lansoprazole or ranitidine. Am J Gastroenterol 2002; 97: 2208-2214 [PMID: 12358234]
55. Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338: 719-726 [PMID: 9494148]
56. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multi-center study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med 2000; 160: 1455-1461 [PMID: 10826458]
57. Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Del Tacca M. Lansoprazole prevents experimental gastric injury induced by non-steroi-dal anti-infammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005; 11: 4052-4060 [PMID: 15996031]
58. Goldstein JL, Johanson JF, Hawkey CJ, Suchower LJ, Brown KA. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole. Aliment Pharmacol Ther 2007; 26: 1101-1111 [PMID: 17894652 DOI: 10.1111/ j.1365-2036.2007.03460.x]
59. Nema H, Kato M. Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. World J Gastroenterol 2010; 16: 5342-5346 [PMID: 21072898 DOI: 10.3748/wjg.v16.i42.5342]
60. Nakashima S, Ota S, Arai S, Yoshino K, Inao M, Ishikawa K, Nakayama N, Imai Y, Nagoshi S, Mochida S. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin. World J Gastroenterol 2009; 15: 727-731 [PMID: 19222098 DOI: 10.3748/wjg.15.727]
61. Jaszewski R, Graham DY, Stromatt SC. Treatment of non-steroidal antiinflammatory drug-induced gastric ulcers with misoprostol. A double-blind multicenter study. Dig Dis Sci 1992; 37: 1820-1824 [PMID: 1473430 DOI: 10.1007/ BF01308074]
62. Sontag SJ, Schnell TG, Budiman-Mak E, Adelman K, Fleis-chmann R, Cohen S, Roth SH, Ipe D, Schwartz KE. Healing of NSAID-induced gastric ulcers with a synthetic prostaglan-din analog (enprostil). Am J Gastroenterol 1994; 89: 1014-1020 [PMID: 8017358]
63. Roth S, Agrawal N, Mahowald M, Montoya H, Robbins D, Miller S, Nutting E, Woods E, Crager M, Nissen C. Misopro-stol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989; 149: 775-779 [PMID: 2495779 DOI: 10.1001/archinte.1989.00390040017004]
64. Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62: 1217-1220 [PMID: 16087761 DOI: 10.1001/archneur.62.8.1217]
65. Arima S, Sakata Y, Ogata S, Tominaga N, Tsuruoka N, Man-nen K, Shiraishi R, Shimoda R, Tsunada S, Sakata H, Iwakiri R, Fujimoto K. Evaluation of hemostasis with soft coagulation using endoscopic hemostatic forceps in comparison with metallic hemoclips for bleeding gastric ulcers: a prospective, randomized trial. J Gastroenterol 2010; 45: 501-505 [PMID: 20033825 DOI: 10.1007/s00535-009-0186-8]
66. Kataoka M, Kawai T, Yagi K, Tachibana C, Tachibana H, Sugimoto H, Hayama Y, Yamamoto K, Nonaka M, Aoki T, Oshima T, Fujiwara M, Fukuzawa M, Fukuzawa M, Kawaka-mi K, Sakai Y, Moriyasu F. Clinical evaluation of emergency endoscopic hemostasis with bipolar forceps in non-variceal upper gastrointestinal bleeding. Dig Endosc 2010; 22: 151-155 [PMID: 20447213 DOI: 10.1111/j.1443-1661.2010.00949.x]
67. Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-973 [PMID: 11274623 DOI: 10.1056/NEJM200103293441304]
68. Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, Chan AO, Lai CL, Wong J. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-2038 [PMID: 12087138 DOI: 10.1056/NEJ-Moa012877]